DPLO - Diplomat Pharmacy, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2018
12/31/2017
12/31/2016
Total Revenue
5,206,257
5,492,524
4,485,230
4,410,388
Cost of Revenue
4,897,069
5,116,515
4,136,552
4,085,560
Gross Profit
309,188
376,009
348,678
324,828
Operating Expense
318,622
335,650
330,113
277,751
Operating Income
-9,434
40,359
18,565
47,077
Net Non Operating Interest Income Expense
-42,696
-41,650
-10,716
-6,573
Other Income Expense
-603,761
-306,017
213
-4,289
Pretax Income
-655,891
-307,308
8,062
36,215
Tax Provision
-6,823
-5,039
-7,126
11,195
Net Income Common Stockholders
-649,068
-302,269
15,510
28,273
Diluted NI Available to Com Stockholders
-649,068
-302,269
15,510
28,273
Basic EPS
-
-0.0041
0
0
Diluted EPS
-
-0.0041
0
0
Basic Average Shares
-
74,245
68,130
65,970
Diluted Average Shares
-
74,245
68,780
68,048
Total Operating Income as Reported
-614,197
-267,285
18,565
47,077
Total Expenses
5,215,691
5,452,165
4,466,665
4,363,311
Net Income from Continuing & Discontinued Operation
-649,068
-302,269
15,510
28,273
Normalized Income
-207,591
-77,689
15,510
28,273
Interest Expense
42,696
41,650
10,716
6,573
Net Interest Income
-42,696
-41,650
-10,716
-6,573
EBIT
-613,195
-265,658
18,778
42,788
EBITDA
-530,112
-
-
-
Reconciled Cost of Revenue
4,897,069
5,116,515
4,136,552
4,085,560
Reconciled Depreciation
83,083
97,112
66,566
50,045
Net Income from Continuing Operation Net Minority Interest
-649,068
-302,269
15,510
28,273
Total Unusual Items Excluding Goodwill
-604,763
-307,644
-
-
Total Unusual Items
-604,763
-307,644
-
-
Normalized EBITDA
74,651
139,098
85,344
92,833
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-163,286
-83,064
0
0